FDA Approved: FOSPHENYTOIN — Supplemental Application (Fresenius Kabi USA, LLC)

View source ↗

Summary

FDA approved a supplemental application for fosphenytoin sodium from Fresenius Kabi USA, LLC under an existing ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures
• Status Epilepticus

Drugs mentioned

• Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

SUPPL AP for FOSPHENYTOIN (FOSPHENYTOIN SODIUM)